Lotus Eye Hospital Institute Ltd vs Modern Diagnostic Research Centre Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Lotus Eye Hospital & Institute Ltd is ₹ 112.75 as of 23 Oct 15:30 . The P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 55.9 on March 2021 to 2533 on March 2026 . This represents a CAGR of 88.83% over 6 yearsThe P/E Ratio of Modern Diagnostic & Research Centre Ltd changed from 15.4 on March 2026 to 15.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 87.14 crore on March 2021 to ₹ 210.77 crore on March 2026 . This represents a CAGR of 15.86% over 6 yearsThe Market Cap of Modern Diagnostic & Research Centre Ltd changed from ₹ 80.96 crore on March 2026 to ₹ 80.96 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 17.27 crore as compare to the Mar '26 revenue of ₹ 14.09 crore. This represent the growth of 22.57% The revenue of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 0.95 crore. This represent the growth of 231.58% The ebitda of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0.62 crore to ₹ 0.61 crore over 9 quarters. This represents a CAGR of -0.72% The net profit of Modern Diagnostic & Research Centre Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Modern Diagnostic & Research Centre Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
Limited' on 14 March, 1997.
The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.

About Modern Diagnostic & Research Centre Ltd

The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992.
Modern Diagnostic & Research Centre Limited was erstwhile incorporated as 'Modern Diagnostic & Research Centre Private Limited' as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi . Thereafter, the Company acquired the business of M/s.
Modern Diagnostics & Research Centre, a Proprietorship Concern through Business Transfer Agreement in 2013.
Subsequently, its status got converted from private limited into public limited and the name of the Company was changed to 'Modern Diagnostic & Research Centre Limited' pursuant to fresh certificate of incorporation dated December 18, 2024 issued by Registrar of Companies, Central Processing Centre.

FAQs for the comparison of Lotus Eye Hospital & Institute Ltd and Modern Diagnostic & Research Centre Ltd

Which company has a larger market capitalization, Lotus Eye Hospital & Institute Ltd or Modern Diagnostic & Research Centre Ltd?

Market cap of Lotus Eye Hospital & Institute Ltd is 234 Cr while Market cap of Modern Diagnostic & Research Centre Ltd is 90 Cr

What are the key factors driving the stock performance of Lotus Eye Hospital & Institute Ltd and Modern Diagnostic & Research Centre Ltd?

The stock performance of Lotus Eye Hospital & Institute Ltd and Modern Diagnostic & Research Centre Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lotus Eye Hospital & Institute Ltd and Modern Diagnostic & Research Centre Ltd?

As of October 25, 2026, the Lotus Eye Hospital & Institute Ltd stock price is INR ₹112.75. On the other hand, Modern Diagnostic & Research Centre Ltd stock price is INR ₹60.0.

How do dividend payouts of Lotus Eye Hospital & Institute Ltd and Modern Diagnostic & Research Centre Ltd compare?

To compare the dividend payouts of Lotus Eye Hospital & Institute Ltd and Modern Diagnostic & Research Centre Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.